Presentation: Whatever Happened to the PT and PTT?
This ASCLS Scientific Session is scheduled for Thursday, July 29, 2-3 PM in the Anaheim Convention Center:
What’s new in antithrombotics? Everything. We now monitor antiplatelet drugs aspirin, clopidogrel, and in 2010, prasugrel. What do we do about fondaparinux, and the 2010 oral anticoagulants rivaroxaban and dabigatran? And we still don’t know how to monitor direct thrombin inhibitors. Are chromogenic X and chromogenic anti-Xa the answer?
Objectives:
- Brief summary of current antithrombotic practice
- Monitor antiplatelet drugs, fondaparinux, direct thrombin inhibitors, and 2010 oral anticoagulants
- Employ chromogenic X and chromogenic anti-Xa to monitor several new anticoagulants.
Here is the handout for this presentation:
Uncategorized | GeorgeFritsma | 
July 21, 2010 2:46 pm
No Comments
No comments yet.
RSS feed for comments on this post. TrackBack URI
Leave a comment
You must be logged in to post a comment.
Subscribe